Extracorporeal Blood Purification Therapy in Critically Ill Patients (GlobalARRT)

RecruitingOBSERVATIONAL
Enrollment

1,000

Participants

Timeline

Start Date

November 1, 2020

Primary Completion Date

September 30, 2025

Study Completion Date

September 30, 2025

Conditions
Critical IllnessAcute Kidney InjurySepsisSystemic Inflammatory Response Syndrome
Interventions
DEVICE

Commercial membrane for Extracorporeal Blood Purification Therapy (EBPT)

At each participating center, EBP treatments with commercial membranes will be delivered in accordance with local practice and local levels of expertise. Enrolled patients will not receive additional treatments other than those routinely administered in ICUs. Nonetheless, all parameters settings for EBP treatments will be recorded in the web-based registry and analyzed a posteriori to reveal potential correlations with patient outcomes.

Trial Locations (1)

50100

RECRUITING

Azienda Ospedaliero Universitaria Careggi, Florence

All Listed Sponsors
collaborator

University of Florence

OTHER

lead

Careggi Hospital

OTHER